Table of Contents

company-logo

Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate targeting Isomesothelin; and ALEXIS-PRO-1, an allogeneic gamma delta chimeric T cell therapy product candidate targeting PD-L1. It has license agreements with CGA 369 Intellectual Holdings, Inc. and Longwood University, as well as a research and development collaboration agreement with Molipharma, S.R.L. The company also has strategic alliance agreement with Leon Office (H.K.) Ltd. The company was formerly known as Kiromic, Inc. and changed its name to Kiromic BioPharma, Inc. in December 2019. Kiromic BioPharma, Inc. was founded in 2006 and is headquartered in Houston, Texas.

Kiromic BioPharma Dividend Announcement

• Kiromic BioPharma does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Kiromic BioPharma dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Kiromic BioPharma Dividend History

Kiromic BioPharma Dividend Yield

Kiromic BioPharma current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Kiromic BioPharma stock? Use our calculator to estimate your expected dividend yield:

Kiromic BioPharma Financial Ratios

P/E ratio-1.34
PEG ratio0.01
P/B ratio-3.63
ROE327.18%
Payout ratio-11.37%
Current ratio0.22
Quick ratio0.22
Cash Ratio0.15

Kiromic BioPharma Dividend FAQ

Does Kiromic BioPharma stock pay dividends?
Kiromic BioPharma does not currently pay dividends to its shareholders.
Has Kiromic BioPharma ever paid a dividend?
No, Kiromic BioPharma has no a history of paying dividends to its shareholders. Kiromic BioPharma is not known for its dividend payments.
Why doesn't Kiromic BioPharma pay dividends?
There are several potential reasons why Kiromic BioPharma would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Kiromic BioPharma ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Kiromic BioPharma has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Kiromic BioPharma a dividend aristocrat?
Kiromic BioPharma is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Kiromic BioPharma a dividend king?
Kiromic BioPharma is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Kiromic BioPharma a dividend stock?
No, Kiromic BioPharma is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Kiromic BioPharma stocks?
To buy Kiromic BioPharma you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Kiromic BioPharma stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.